Meeting
2019 ASCO Annual Meeting
Effect on pain outcomes in patients treated for painful bone metastases with biopolar RFA: The OPuS One study.
Authors
Sandeep Bagla
Vascular Institute of Virginia, Woodbridge, VA
Sandeep Bagla , Jason Levy , Thomas Hopkins
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Symptoms and Survivorship
Track
Symptom Science and Palliative Care
Sub Track
Palliative Care and Symptom Management
Clinical Trial Registration Number
NCT03249584
Citation
J Clin Oncol 37, 2019 (suppl; abstr 11605)
DOI
10.1200/JCO.2019.37.15_suppl.11605
Abstract #
11605
Poster Bd #
297
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Radiofrequency ablation for palliative treatment of osseous metastases results in rapid, significant, and durable improvements in pain relief and quality of life: Results from the OPuS One trial.
First Author: Jason Levy
Poster
2015 Genitourinary Cancers Symposium
External beam radiation therapy (EBRT) use and safety with radium-223 dichloride (Ra-223) in patients (pts) with castration-resistant prostate cancer (CRPC) and symptomatic bone metastases (mets) from the ALSYMPCA trial.
First Author: Steven E. Finkelstein
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Infusional fluorouracil and weekly docetaxel as first-line therapy for gastric cancer with bone marrow metastasis and disseminated intravascular coagulation: A multi-center, phase II trial (Zhen Long).
First Author: Jian Xiao
Poster
2023 ASCO Annual Meeting
A prospective, open-label, randomized, controlled trial of radiofrequency ablation versus stereotactic body radiation therapy for recurrent small hepatocellular carcinoma.
First Author: Yaojun Zhang